OUR MISSION

Using artificial intelligence to revolutionize cancer diagnosis

To assist in diagnosis and quality control of histological tests, NGD-Lab provides pathologists with the power of artificial intelligence and the techniques of digital pathology.

Our integrated digital platform enables users to benefit from solutions proposed by our partners who are among the most advanced players in the field of artificial intelligence and anatomical-cyto pathology analysis.

NGD-Lab aims to play a central role in the future of cancer screening and pathological diagnosis. Through our services platform we want to facilitate the improvement and acceleration of the patient diagnosis process and treatment.

ARTIFICIAL INTELLIGENCE

Serving pathologists

We combine our in-depth knowledge in your field with that of artificial intelligence analysis to offer you a wide range of algorithms to assist in diagnosis.

Artificial intelligence slide analysis optimizes and strengthens diagnostic accuracy and thus the prognosis prediction for the patient.

Our diagnostic support solutions help to save medical time and optimize the reliability of the results. Exchange, reading and training are facilitated through a wide organizational flexibility.

SOLUTIONS

A wide range of algorithms

PARTNERS

Leaders in their field

IMMEDIATE BENEFITS

Optimize the work of pathologists

The use of AI provides the pathologist with improved precision while saving time and improving efficiency, for better focus and enabling to concentrate on complex cases.

Reduce processing times and make your centre more efficient

Slide reading time is considerably shorter using AI. This reduces diagnosis time by 27% allowing for an average of 37% increase in productivity *

*Study 2020 UTHSC: University of Tennessee Health Science Centre on 450 prostate biopsies.

Improve the quality of diagnosis

Classification based on AI, heatmaps, and automated measurements significantly improve the effectiveness of diagnosis and the quality of prostate biopsy reports*

*Study 2021: UTHSC, MUV, CHU Rennes on 785 H&E slides of consecutive 100 PCNB cases.

New cancer cases in 2018 in metropolitan France – Source National Cancer Institute

NEW
CANCERS
BREAST
CANCER
PROSTATE
CANCER
GYNECOLOGICAL
CANCER

CONTACT

OUR MISSION

Using artificial intelligence to revolutionize cancer diagnosis

To assist in diagnosis and quality control of histological tests, NGD-Lab provides pathologists with the power of artificial intelligence and the techniques of digital pathology.

Our integrated digital platform enables users to benefit from solutions proposed by our partners who are among the most advanced players in the field of artificial intelligence and anatomical-cyto pathology analysis.

NGD-Lab aims to play a central role in the future of cancer screening and pathological diagnosis. Through our services platform we want to facilitate the improvement and acceleration of the patient diagnosis process and treatment.

ARTIFICIAL INTELLIGENCE

Serving pathologists

We combine our in-depth knowledge in your field with that of artificial intelligence analysis to offer you a wide range of algorithms to assist in diagnosis.

Artificial intelligence slide analysis optimizes and strengthens diagnostic accuracy and thus the prognosis prediction for the patient.

Our diagnostic support solutions help to save medical time and optimize the reliability of the results. Exchange, reading and training are facilitated through a wide organizational flexibility.

SOLUTIONS

A wide range of algorithms

PARTNERS

Leaders in their field

IMMEDIATE BENEFITS

Optimize the work of pathologists

The use of AI provides the pathologist with improved precision while saving time and improving efficiency, for better focus and enabling to concentrate on complex cases.

Reduce processing times and make your centre more efficient

Slide reading time is considerably shorter using AI. This reduces diagnosis time by 27% allowing for an average of 37% increase in productivity *

*Study 2020 UTHSC: University of Tennessee Health Science Centre on 450 prostate biopsies.

Improve the quality of diagnosis

Classification based on AI, heatmaps, and automated measurements significantly improve the effectiveness of diagnosis and the quality of prostate biopsy reports*

*Study 2021: UTHSC, MUV, CHU Rennes on 785 H&E slides of consecutive 100 PCNB cases.

New cancer cases in 2018 in metropolitan France – Source National Cancer Institute

NEW
CANCERS
BREAST
CANCER
PROSTATE
CANCER
GYNECOLOGICAL
CANCER

CONTACT

ADDRESS

17 rue Gazan – 75014 Paris

PHONE

+33 (0) 1 85 14 13 62

E-MAIL

l.francheteau@ngd-lab.com

vCard

REQUESTS FOR INFORMATION AND DEMOS